
Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>




































Captured Human TSLP (R127A, R130A), His Tag (Cat. No. TSP-H52Ha) on CM5 Chip via anti-His antibody, can bind Human TSLP R, Fc Tag (Cat. No. TSR-H525a) with an affinity constant of 4.22 nM as determined in SPR assay (Biacore T200) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tezepelumab | AMG-157; MEDI-9929 | Approved | Amgen Inc | Tezspire | Japan | Asthma | Astrazeneca Kk | 2021-12-17 | Eosinophilic Esophagitis; Dermatitis, Atopic; Hypersensitivity; Pulmonary Disease, Chronic Obstructive; Bronchial Diseases; Hypersensitivity, Immediate; Sinusitis; Respiratory Hypersensitivity; Asthma; Lung Diseases, Obstructive; Immune System Diseases; Lung Diseases; Respiratory Tract Diseases; Nasal Polyps; Nose Diseases; Chronic Urticaria; Anaphylaxis; Carcinoma | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| AZD-8630 | AZD-8630; AMG-104 | Astrazeneca Plc, Amgen Inc | Details | ||
| BSI-045B | BSI-045B | Boaoxin Biotechnology(Nanjing) Co Ltd | Details | ||
| SAR-443765 | SAR-443765 | Phase 1 Clinical | Sanofi | Inflammation | Details |
| MK-8226 | MK-8226 | Merck & Co Inc | Details | ||
| ASP-7266 | UPB-101; ASP-7266 | Phase 1 Clinical | Astellas Pharma Inc, Upstream Biosciences Inc | Asthma | Details |
| QX-008N | QX-008N; QX008N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma | Details |
| HBM-9378 | SKB378; HBM-9378 | Phase 1 Clinical | Harbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Asthma | Details |
| GR-1802 | GR-1802 | Phase 2 Clinical | Zhixiang (Shanghai) Pharmaceutical Technology Co Ltd | Asthma; Sinusitis; Dermatitis, Atopic | Details |
| Ecleralimab | CSJ-117; NOV-14 | Phase 2 Clinical | Novartis Pharma Ag | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| SHR-1905 | SHR-1905 | Phase 2 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Asthma | Details |
| CM-326(Connaught Biomedical Technology) | CM-326 | Phase 2 Clinical | Keymed Biosciences Co Ltd | Nose Diseases; Nasal Polyps; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
This web search service is supported by Google Inc.




